RetiSpec
PrivateLast Round
Series A
Jul 26, 2024
Total Funding Raised
$17M
Company Overview
RetiSpec is a health tech company that provides a platform for the early detection of neurodegenerative diseases through a non-invasive eye exam.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RetiSpec Comparables
Compare RetiSpec with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Optina Diagnostics | 91% | |
| NeuroVision Imaging | 87% | |
| Cognoptix | 78% |
RetiSpec Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 26, 2024 | ||||
| Grant | Jul 7, 2023 | ||||
| Grant | Apr 13, 2023 | ||||
| Grant | May 25, 2022 | ||||
| Seed | Feb 1, 2020 | ||||
Grant | Oct 8, 2019 |
RetiSpec Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ontario Brain Institute | Grant, Seed, Series A |
| Verge HealthTech Fund | Seed, Series A |
| Discovery Capital Funding | Seed, Series A |
| Davos Alzheimer's Collaborative | Grant |
| iGan Partners | Series A |
| Centre for Aging and Brain Health Innovation | Seed, Series A, Grant |
| Alzheimer's Drug Discovery Foundation | Grant, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2024
$10M round led by iGan Partners.
- Apr 13, 2023
Received grant funding from Centre for Aging and Brain Health Innovation.
RetiSpec Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about RetiSpec's valuation, stock price, and market status.
Is RetiSpec a public or private company?
RetiSpec is a private company.
What is the current stock price of RetiSpec?
RetiSpec is a private company with no public stock price. No recent secondary market data is available.
How much is RetiSpec worth (valuation)?
Valuation information for RetiSpec is not publicly available.
Can I buy RetiSpec stock?
RetiSpec shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was RetiSpec's last funding round?
RetiSpec's most recent funding round was Series A on July 26, 2024.
Who are the main investors in RetiSpec?
Key investors in RetiSpec include iGan Partners.
Will RetiSpec IPO soon?
No public IPO plans have been announced for RetiSpec.
How can I track RetiSpec secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor RetiSpec's secondary market activity and sign up for updates.